Back to results
US 11,028,411 B2Granted
Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA
AssigneeEditas Medicine, Inc.
InventorsAri E. Friedland, Hariharan Jayaram, Barrett Ethan Steinberg
Life of this patent
Estimating the term…
Abstract
Engineered nucleic acids encoding genome editing system components are provided, as are engineered RNA-guided nucleases that include inserts encoded in part by cellular genomic or other sequences recognized by guide RNAs.
Claims28
A method of altering a target site in a cell comprising delivering to the cell a transiently active genome editing system comprising a guide RNA (gRNA) and an engineered Cas9 protein, or a nucleic acid composition encoding the gRNA and the Cas9 protein, wherein
- a) the gRNA comprises a targeting domain that is complementary to a eukaryotic nucleic acid sequence;
- and
- b) the Cas9 protein is encoded by a nucleic acid comprising the eukaryotic nucleotide sequence and a protospacer adjacent motif (PAM), wherein the PAM is recognized by the Cas9 protein and is within or adjacent to the eukaryotic nucleotide sequence, and wherein the Cas9 protein comprises:
- i) an amino acid insertion relative to SEQ ID NO:
- 2 selected from the group consisting of:
- E271_N272insGX6-10G, L371_N372insGX6-10G, and Q737_A738insGX6-10G;
- or
- ii) an amino acid insertion S12_M13insGX6-10G relative to SEQ ID NO:
- 10,
- wherein the amino acid insertion relative to SEQ ID NO:2 or SEQ ID NO:
- 10 results in a polypeptide comprising an amino acid sequence having at least 95% sequence identity to the sequence set forth in SEQ ID NO:
- 3, SEQ ID NO:
- 4, SEQ ID NO:
- 5, or SEQ ID NO:
- 10, and having an RNA-guided nuclease activity.
12 more elements
Dependencies are inferred from the claim text.